Cite
Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently.
MLA
Evans, Marc, et al. “Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently.” Diabetes Therapy, vol. 13, no. 5, May 2022, pp. 889–911. EBSCOhost, https://doi.org/10.1007/s13300-022-01242-y.
APA
Evans, M., Morgan, A. R., Bain, S. C., Davies, S., Dashora, U., Sinha, S., Seidu, S., Patel, D. C., Beba, H., & Strain, W. D. (2022). Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently. Diabetes Therapy, 13(5), 889–911. https://doi.org/10.1007/s13300-022-01242-y
Chicago
Evans, Marc, Angharad R. Morgan, Stephen C. Bain, Sarah Davies, Umesh Dashora, Smeeta Sinha, Samuel Seidu, Dipesh C. Patel, Hannah Beba, and W. David Strain. 2022. “Defining the Role of SGLT2 Inhibitors in Primary Care: Time to Think Differently.” Diabetes Therapy 13 (5): 889–911. doi:10.1007/s13300-022-01242-y.